Prediction of Responsiveness to PD-L1/PD-1 Inhibitors Using miRNA Profiles Associated With PD-L1 Expression in Lung Adenocarcinoma and Squamous Cell Carcinoma
Anticancer Research · 2024
DOI: 10.21873/anticanres.17012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Young Wha Koh und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Ajou University School of Medicine, Gyeonggi-do, Republic of Korea; youngwha9556@gmail.com. Hauptthemen laut MEDLINE: MicroRNAs, B7-H1 Antigen, Lung Neoplasms, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Ajou University School of Medicine, Gyeonggi-do, Republic of Korea; youngwha9556@gmail.com.
- Department of Pathology, Ajou University School of Medicine, Gyeonggi-do, Republic of Korea.
- Department of Thoracic and Cardiovascular Surgery, Ajou University School of Medicine, Gyeonggi-do, Republic of Korea.
- Department of Hematology-Oncology, Ajou University School of Medicine, Gyeonggi-do, Republic of Korea.
Zitieren
APA
Koh, Y. W., Han, J. H., Haam, S., & Lee, H. W. (2024). Prediction of Responsiveness to PD-L1/PD-1 Inhibitors Using miRNA Profiles Associated With PD-L1 Expression in Lung Adenocarcinoma and Squamous Cell Carcinoma. Anticancer Research. https://doi.org/10.21873/anticanres.17012
Vancouver
Koh YW, Han JH, Haam S, Lee HW. Prediction of Responsiveness to PD-L1/PD-1 Inhibitors Using miRNA Profiles Associated With PD-L1 Expression in Lung Adenocarcinoma and Squamous Cell Carcinoma. Anticancer Research. 2024. doi:10.21873/anticanres.17012
BibTeX
@article{Koh2024,
author = {Koh, Young Wha and Han, Jae-Ho and Haam, Seokjin and Lee, Hyun Woo},
title = {Prediction of Responsiveness to PD-L1/PD-1 Inhibitors Using miRNA Profiles Associated With PD-L1 Expression in Lung Adenocarcinoma and Squamous Cell Carcinoma},
journal = {Anticancer Research},
year = {2024},
doi = {10.21873/anticanres.17012}
}
EUVIMED